Policy debates often return to scheduling and bans. India and The usa both of those experience variations of a similar query: whether or not to impose broader, class-extensive controls above fentanyl analogs as well as their precursors, or to maintain material-by-substance scheduling that will lag at the rear of traffickers’ innovation.A bold and